{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/(IDF_822) US20210395795A1_Janice.pdf"}, "page_content": "ing peptide with at least one ( preferably one ) lysine within\n\nthe peptide being substituted with a lipoyl group , and R\n\nASVT\n\ncomprises a photo - crosslinking group attached to the lysine\n\nN\n\nSD\n\nH\n\ncontaining peptide via a carbonyl group and the second\n\nNEN\n\ncompound has a structure of formula R - X , wherein X is\n\na lysine - containing peptide , and Ry comprises a photo\n\ncrosslinking group attached to the lysine containing peptide\n\nvia a carbonyl group .\n\nHN\n\n[ 0025 ]\n\nOptionally , the lysine containing peptide of the first\n\ncompound is the same as the lysine containing compound of\n\nthe second compound .\n\n[ 0026 ]\n\nIn certain embodiments of the method X of the first\n\nand second compounds comprises a peptide sequence of a\n\nprotein selected from : branched - chain a - ketoacid dehydro\n\ngenase ( BCKDH ) , a - ketoglutarate dehydrogenase ( KDH ) ,\n\npyruvate dehydrogenase ( PDH ) , glycine cleavage complex\n\n( GCV ) , and histone .\n\nFormula ( III )\n\n[ 0027 ]\n\nIn certain embodiments of the method Ry further\n\ncontains an alkynyl group .\n\nASVT\n\nSD\n\nN\n\n[ 0028 ]\n\nIn certain embodiments of the method X of the first\n\nH\n\nand second compounds comprises a peptide sequence of a\n\nNEN\n\nprotein selected from branched - chain a - ketoacid dehydro\n\ngenase ( BCKDH ) , a - ketoglutarate dehydrogenase ( KDH ) ,\n\npyruvate dehydrogenase ( PDH ) , glycine cleavage complex\n\n( GCV ) , or histone ; and R , further contains an alkynyl group ;\n\nH2N\n\npreferably the first compound is substituted with a lipoyl\n\ngroup while the second compound is not .\n\nwherein S , D , A , S , V and T represent amino acids using the\n\n[ 0029 ]\n\nIn certain embodiments the first and second com\n\none letter amino acid code .\n\npounds comprise the same peptide sequence .\n\n[ 0021 ]\n\nPreferably , the compound of formula R - X has a\n\n1\n\n[ 0030 ]\n\nIn certain embodiments the first compound has a\n\nstructure of Formula ( II ) .\n\n[ 0022 ]\n\nIn a second aspect of the present invention , there is", "type": "Document"}}